Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study (MDMN)
Primary Purpose
Depression, Anxiety
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TDCS - transcranial direct current stimulation
Sponsored by

About this trial
This is an interventional other trial for Depression, Anxiety
Eligibility Criteria
Inclusion Criteria:
- Between 18-30years old
- Score > 10 on the QIDS or > 60 on the PROMIS-A
- We will use a flexible extreme groups recruitment strategy to ensure an adequate distribution of ESC scores. We will ensure that at least 62% of the sample will be composed of those scoring .5 SD above or below the mean, as measured by the NEO-PI-R. This value corresponds to the expected values assuming a normal distribution of the trait.
- Normal or corrected to normal vision with contact lenses
- Able to provide informed consent in English
- Right-handed (Annett criteria)
Exclusion Criteria:
- Have a history of head trauma with loss of consciousness.
- Have a systemic medical illness that may impact fMRI measures of cerebral blood flow.
- Meet standard exclusion criteria for fMRI scanning (e.g. claustrophobia, cardiac pacemakers, neural pacemakers, surgically implanted metal devices, cochlear implants, metal braces, or other MRI non-safe metal objects in the body).
- Are pregnant (self report and tested for as part of any scan by the scanning center and not this protocol)
- Not native English speaking or not fluent
- Premorbid NAART IQ estimate<85;
- Visual disturbance (worse than 20/40 Snellen visual acuity) that is not corrected
- If have visual disturbance, only access to correction with glasses (i.e., no access to contact lenses).
- Left/mixed handedness (Annett criteria), to ensure a uniform hemispheric dominance for interpretation of neuroimaging data
- Active suicidal ideation in need of immediate treatment
- Scoring below the cutoffs on both the QIDS and the PROMIS-A
- History of alcohol/substance use disorder (including nicotine) and/or illicit substance use (except cannabis) over the last 3 months, determined by the MINI. Lifetime/present cannabis use (non-disordered levels) will be allowed, given its common usage in individuals in this age range.
- Current or past psychotic-spectrum disorder
- History of seizures
Sites / Locations
- University of Pittsburgh
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Transcranial Direct Current Stimulation during fMRI
Arm Description
Each subject will undergo transcranial direct current stimulation twice while completing a task in the functional magnetic resonance imaging scanner.
Outcomes
Primary Outcome Measures
Blood Oxygen Level Dependent (BOLD) Response in the Precuneus During an Emotion Regulation Task Completed During fMRI Scanning.
The investigators will determine the effects of TDCS on BOLD response in the precuneus/posterior cingulate gyrus. The BOLD signal is a measure of regional blood flow in the brain and is used as a proxy for neural activity in specific brain regions.
Values below represent pre-post change in BOLD response to the emotion regulation task that participants complete during fMRI scanning. We hypothesize that tDCS applied to the target used in this study will decrease BOLD signal (lower values) during critical components of this task, normalizing function in this region.
Secondary Outcome Measures
The Percentage of Patients Who Reported a Side Effect in the Active tDCS Condition But Not the Sham tDCS Condition
Potential side effects (e.g., headaches, dizziness, uncomfortable sensations, etc...) will be assessed after each tDCS and sham-tDCS administration. Side effects were assessed using a standardized form.
Count below represents the number of participants who reported a mild or moderate side effect during active tDCS but not sham tDCS.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04598152
Brief Title
Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study
Acronym
MDMN
Official Title
Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Covid restrictions prevented continuation during the funding window
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
March 9, 2020 (Actual)
Study Completion Date
March 9, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jay Fournier
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary purpose of this research is to gather scientific information about how different people's brains work when they look at different types of pictures. This will help to improve the investigators' understanding of the way the brain works for people who are depressed or anxious, and this knowledge could help lead to better diagnosis and treatment.
Detailed Description
In this study the investigators are examining the effects of weak electrical stimulation on brain activity as measured by functional magnetic resonance imaging (fMRI). MRI is a widely used method to obtain high resolution brain pictures that are routinely used for diagnostic and clinical purposes. The electrical stimulation is applied on the scalp with a non-FDA approved method called tDCS (transcranial Direct Current Stimulation), typically equivalent to what a 6V battery would produce (and up to no more than 15V). To compare, an AA battery delivers current at 1.5 volt. While almost unnoticeable to the participants, these currents can still temporarily affect brain activity without causing adverse effects. This stimulation would be applied while the participants are in the MRI scanner so that the brain activity can be measured. The participants will have the opportunity to have a test session with the stimulation outside the scanner to get familiar with it.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The first part of the study consists of screening procedures that are meant to determine if potential participants are eligible to take part in the remainder of the study.
If you qualify to take part in the scanning portion of the study, you will have 2 scanning sessions on separate days approximately a week apart. For each scan session you will undergo a functional Magnetic Resonance Imaging (fMRI) scan that lasts approximately 30 minutes and no more than 1 hour. The total time you will spend for each scan session will be between 1-3 hours.
During the scanning session you will receive transcranial direct current stimulation (tDCS). Prior to scanning, sponge-electrodes will be placed on your scalp. These electrodes will be connected to a stimulator. This stimulator will apply weak currents to the brain while the MRI takes pictures of your brain's responses. The stimulation current that you will experience is usually less than a 6-volt battery but may be increased up to 15-volts.
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Transcranial Direct Current Stimulation during fMRI
Arm Type
Experimental
Arm Description
Each subject will undergo transcranial direct current stimulation twice while completing a task in the functional magnetic resonance imaging scanner.
Intervention Type
Device
Intervention Name(s)
TDCS - transcranial direct current stimulation
Intervention Description
TDCS involves passing a weak current through the brain. One variant, cathodal TDCS, can be used to temporarily hyperpolarize cortical pyramidal cells, thereby decreasing neuronal connections. TDCS has been explored as a possible treatment for depression, but results to date are mixed. No work has examined whether TDCS can be used in an individually guided manner to target locations in the parietal cortex and alter the patterns of circuitry dysfunction described previously.
Primary Outcome Measure Information:
Title
Blood Oxygen Level Dependent (BOLD) Response in the Precuneus During an Emotion Regulation Task Completed During fMRI Scanning.
Description
The investigators will determine the effects of TDCS on BOLD response in the precuneus/posterior cingulate gyrus. The BOLD signal is a measure of regional blood flow in the brain and is used as a proxy for neural activity in specific brain regions.
Values below represent pre-post change in BOLD response to the emotion regulation task that participants complete during fMRI scanning. We hypothesize that tDCS applied to the target used in this study will decrease BOLD signal (lower values) during critical components of this task, normalizing function in this region.
Time Frame
1 week (between baseline and repeat scanning)
Secondary Outcome Measure Information:
Title
The Percentage of Patients Who Reported a Side Effect in the Active tDCS Condition But Not the Sham tDCS Condition
Description
Potential side effects (e.g., headaches, dizziness, uncomfortable sensations, etc...) will be assessed after each tDCS and sham-tDCS administration. Side effects were assessed using a standardized form.
Count below represents the number of participants who reported a mild or moderate side effect during active tDCS but not sham tDCS.
Time Frame
30 minutes to 1 hour (the period during which the tDCS device was worn) on each of two scan days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Between 18-30years old
Score > 10 on the QIDS or > 60 on the PROMIS-A
We will use a flexible extreme groups recruitment strategy to ensure an adequate distribution of ESC scores. We will ensure that at least 62% of the sample will be composed of those scoring .5 SD above or below the mean, as measured by the NEO-PI-R. This value corresponds to the expected values assuming a normal distribution of the trait.
Normal or corrected to normal vision with contact lenses
Able to provide informed consent in English
Right-handed (Annett criteria)
Exclusion Criteria:
Have a history of head trauma with loss of consciousness.
Have a systemic medical illness that may impact fMRI measures of cerebral blood flow.
Meet standard exclusion criteria for fMRI scanning (e.g. claustrophobia, cardiac pacemakers, neural pacemakers, surgically implanted metal devices, cochlear implants, metal braces, or other MRI non-safe metal objects in the body).
Are pregnant (self report and tested for as part of any scan by the scanning center and not this protocol)
Not native English speaking or not fluent
Premorbid NAART IQ estimate<85;
Visual disturbance (worse than 20/40 Snellen visual acuity) that is not corrected
If have visual disturbance, only access to correction with glasses (i.e., no access to contact lenses).
Left/mixed handedness (Annett criteria), to ensure a uniform hemispheric dominance for interpretation of neuroimaging data
Active suicidal ideation in need of immediate treatment
Scoring below the cutoffs on both the QIDS and the PROMIS-A
History of alcohol/substance use disorder (including nicotine) and/or illicit substance use (except cannabis) over the last 3 months, determined by the MINI. Lifetime/present cannabis use (non-disordered levels) will be allowed, given its common usage in individuals in this age range.
Current or past psychotic-spectrum disorder
History of seizures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jay C Fournier, Ph. D.
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study
We'll reach out to this number within 24 hrs